Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Microextraction sample preparation techniques in forensic analytical toxicology.

He Y, Concheiro-Guisan M.

Biomed Chromatogr. 2019 Jan;33(1):e4444. doi: 10.1002/bmc.4444. Review.

PMID:
30468511
2.

First metabolic profile of PV8, a novel synthetic cathinone, in human hepatocytes and urine by high-resolution mass spectrometry.

Swortwood MJ, Ellefsen KN, Wohlfarth A, Diao X, Concheiro-Guisan M, Kronstrand R, Huestis MA.

Anal Bioanal Chem. 2016 Jul;408(18):4845-56. doi: 10.1007/s00216-016-9599-4. Epub 2016 May 16.

PMID:
27185540
3.

In vitro, in vivo and in silico metabolic profiling of α-pyrrolidinopentiothiophenone, a novel thiophene stimulant.

Swortwood MJ, Carlier J, Ellefsen KN, Wohlfarth A, Diao X, Concheiro-Guisan M, Kronstrand R, Huestis MA.

Bioanalysis. 2016;8(1):65-82. doi: 10.4155/bio.15.237. Epub 2015 Dec 9.

4.

One Hundred False-Positive Amphetamine Specimens Characterized by Liquid Chromatography Time-of-Flight Mass Spectrometry.

Marin SJ, Doyle K, Chang A, Concheiro-Guisan M, Huestis MA, Johnson-Davis KL.

J Anal Toxicol. 2016 Jan-Feb;40(1):37-42. doi: 10.1093/jat/bkv101. Epub 2015 Sep 4.

5.

Phase I and II cannabinoid disposition in blood and plasma of occasional and frequent smokers following controlled smoked cannabis.

Desrosiers NA, Himes SK, Scheidweiler KB, Concheiro-Guisan M, Gorelick DA, Huestis MA.

Clin Chem. 2014 Apr;60(4):631-43. doi: 10.1373/clinchem.2013.216507. Epub 2014 Feb 21.

6.

In vitro stability of free and glucuronidated cannabinoids in urine following controlled smoked cannabis.

Desrosiers NA, Lee D, Scheidweiler KB, Concheiro-Guisan M, Gorelick DA, Huestis MA.

Anal Bioanal Chem. 2014 Jan;406(3):785-92. doi: 10.1007/s00216-013-7524-7. Epub 2013 Dec 1.

7.

Urinary cannabinoid disposition in occasional and frequent smokers: is THC-glucuronide in sequential urine samples a marker of recent use in frequent smokers?

Desrosiers NA, Lee D, Concheiro-Guisan M, Scheidweiler KB, Gorelick DA, Huestis MA.

Clin Chem. 2014 Feb;60(2):361-72. doi: 10.1373/clinchem.2013.214106. Epub 2013 Nov 1.

8.

A test of the cognitive self-medication hypothesis of tobacco smoking in schizophrenia.

Hahn B, Harvey AN, Concheiro-Guisan M, Huestis MA, Holcomb HH, Gold JM.

Biol Psychiatry. 2013 Sep 15;74(6):436-43. doi: 10.1016/j.biopsych.2013.03.017. Epub 2013 May 6.

9.

Urinary excretion of buprenorphine, norbuprenorphine, buprenorphine-glucuronide, and norbuprenorphine-glucuronide in pregnant women receiving buprenorphine maintenance treatment.

Kacinko SL, Jones HE, Johnson RE, Choo RE, Concheiro-Guisan M, Huestis MA.

Clin Chem. 2009 Jun;55(6):1177-87. doi: 10.1373/clinchem.2008.113712. Epub 2009 Mar 26.

10.

Simultaneous quantification of buprenorphine, norbuprenorphine, buprenorphine glucuronide, and norbuprenorphine glucuronide in human placenta by liquid chromatography mass spectrometry.

Concheiro-Guisan M, Shakleya DM, Huestis MA.

Anal Bioanal Chem. 2009 May;394(2):513-22. doi: 10.1007/s00216-009-2706-z. Epub 2009 Feb 27.

11.

Development and validation of a liquid chromatography-tandem mass spectrometry assay for the simultaneous quantification of buprenorphine, norbuprenorphine, and metabolites in human urine.

Kacinko SL, Concheiro-Guisan M, Shakleya DM, Huestis MA.

Anal Bioanal Chem. 2008 Nov;392(5):903-11. doi: 10.1007/s00216-008-2326-z. Epub 2008 Aug 30.

Supplemental Content

Loading ...
Support Center